<VariationArchive RecordType="classified" VariationID="640444" VariationName="NC_000016.10:g.(?_68801660)_(68801903_?)del" VariationType="Deletion" Accession="VCV000640444" Version="7" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-11-11" DateCreated="2019-08-14" MostRecentSubmission="2023-11-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="653143" VariationID="640444">
      <GeneList>
        <Gene Symbol="CDH1" FullName="cadherin 1" GeneID="999" HGNC_ID="HGNC:1748" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="68737292" stop="68835537" display_start="68737292" display_stop="68835537" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="68771194" stop="68869443" display_start="68771194" display_stop="68869443" Strand="+" />
          </Location>
          <OMIM>192090</OMIM>
          <Haploinsufficiency last_evaluated="2020-04-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDH1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-04-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDH1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000016.10:g.(?_68801660)_(68801903_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16q22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" innerStart="68801660" innerStop="68801903" display_start="68801660" display_stop="68801903" variantLength="244" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" innerStart="68835563" innerStop="68835806" display_start="68835563" display_stop="68835806" variantLength="244" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.(?_68801660)_(68801903_?)del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.(?_68801660)_(68801903_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.(?_68835563)_(68835806_?)del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.(?_68835563)_(68835806_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000016.10:g.(?_68801660)_(68801903_?)del AND Hereditary diffuse gastric adenocarcinoma" Accession="RCV000793473" Version="6">
        <ClassifiedConditionList TraitSetID="3314">
          <ClassifiedCondition DB="MedGen" ID="C1708349">Hereditary diffuse gastric adenocarcinoma</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-06-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-06-27" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-08-14" MostRecentSubmission="2023-11-11">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15235021</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20373070</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21777349</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3314" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1360" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary diffuse gastric adenocarcinoma</ElementValue>
                <XRef ID="MONDO:0007648" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary diffuse gastric cancer</ElementValue>
                <XRef ID="Hereditary+diffuse+gastric+cancer/8514" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HDGC</ElementValue>
                <XRef Type="MIM" ID="137215" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10900" />
                <XRef ID="10900" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Hereditary diffuse gastric cancer (HDGC) is an autosomal dominant susceptibility for diffuse gastric cancer, a poorly differentiated adenocarcinoma that infiltrates into the stomach wall causing thickening of the wall (linitis plastica) without forming a distinct mass. Diffuse gastric cancer is also referred to as signet ring carcinoma or isolated cell-type carcinoma. The average age of onset of HDGC is 38 years (range: 14-69 years). The majority of the cancers in individuals with a CDH1 pathogenic variant occur before age 40 years. The estimated cumulative risk of gastric cancer by age 80 years is 70% for men and 56% for women. Women are also at a 42% risk for lobular breast cancer.</Attribute>
                <XRef ID="NBK1139" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301318</ID>
                <ID Source="BookShelf">NBK1139</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACS, 2007">
                <ID Source="PubMed">17392385</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2010">
                <ID Source="PubMed">20065170</ID>
              </Citation>
              <Citation Type="general" Abbrev="IGCLC, 2010">
                <ID Source="pmc">2991043</ID>
              </Citation>
              <Citation Type="general" Abbrev="Klujit et al., 2012">
                <ID Source="PubMed">22388873</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACG, 2015">
                <ID Source="PubMed">25645574</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Breast and Gynecologic Cancers">
                <ID Source="PubMed">26389210</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2015">
                <ID Source="PubMed">26324357</ID>
              </Citation>
              <Citation Type="general" Abbrev="IGCLC, 2020">
                <ID Source="PubMed">32758476</ID>
                <ID Source="pmc">7116190</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2023">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN GuidelinesÂ®) Gastric Cancer, 2023</CitationText>
              </Citation>
              <XRef ID="26106" DB="Orphanet" />
              <XRef ID="C1708349" DB="MedGen" />
              <XRef ID="MONDO:0007648" DB="MONDO" />
              <XRef Type="MIM" ID="137215" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1826618" SubmissionDate="2023-02-03" DateLastUpdated="2023-11-11" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="NM_004360.3_Deletion (Exon 3)|MedGen:C1708349" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000932825" DateUpdated="2023-11-11" DateCreated="2019-08-14" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15235021</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20373070</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21777349</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21777349</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon(s) 3 of the CDH1 gene. This deletion is out-of-frame, and is expected to create a premature termination codon and result in an absent or disrupted protein product. Loss-of-function variants in CDH1 are known to be pathogenic (PMID: 15235021, 20373070). A similar copy number variant has been observed in individual(s) with gastric cancer (PMID: 21777349). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that a similar copy number variant affects CDH1 function (PMID: 21777349). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CDH1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.(?_68835563)_(68835806_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1708349" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB6933794</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1826618" TraitType="Disease" MappingType="XRef" MappingValue="C1708349" MappingRef="MedGen">
        <MedGen CUI="C1708349" Name="Hereditary diffuse gastric adenocarcinoma" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

